Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05576350 · ClinicalTrials.gov registry record · NA

TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

A NA study of HIV Infections and Alcohol Use Disorder, sponsored by University of Kentucky.

Recruiting
Registry status
NA
Development phase
405
Enrollment target
2
Study locations

NCT05576350 is a NA study of HIV Infections and Alcohol Use Disorder that is actively recruiting participants, run by University of Kentucky. The registered enrollment target is 405 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05576350, a NA study of HIV Infections and Alcohol Use Disorder, is actively recruiting participants, sponsored by University of Kentucky.

RECRUITING
Registry status
NA
Development phase
405 participants
Enrollment target
2
Study locations

Study Summary

Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use. A mobile app has been developed that uses GPS tracking to determine when individuals visit "risky" places and then delivers a survey asking what behaviors they engaged in while at the location. The goal of the proposed study is to use this app to enhance the Tracking and Reducing Alcohol Consumption (TRAC) intervention by delivering messages that encourage participants to employ strategies discussed during TRAC sessions when arriving at risky places. When they leave these places, they will complete a survey and breathalyzer reading in order to collect event-level self-report and biological data on alcohol use and HIV risk. If their breathalyzer result indicates alcohol use, they will receive harm reduction messaging. It is expected that combining TRAC with EMI ("TRAC-ER") will increase effectiveness by reinforcing topics discussed during these sessions, providing in-the-moment messaging to address triggers, and collecting real-time alcohol use data.

Conditions Studied

HIV Infections Alcohol Use Disorder Risk Behavior

Interventions

  • BEHAVIORAL Smartphone Based Alcohol Monitoring (SAM)
  • BEHAVIORAL Tracking and Reducing Alcohol Consumption (TRAC)
  • BEHAVIORAL TRAC-ER

Study Locations (2)

Connecticut

  • Yale University - New Haven

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 405 participants
Start Date 2024-12-09
Est. Completion 2027-05
Phase NA

Sponsor

University of Kentucky

54 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05576350

The ClinicalTrials.gov registry entry for NCT05576350 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Smartphone Based Alcohol Monitoring (SAM) is the first listed.

NCT05576350 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Kentucky.

Frequently Asked Questions

What is clinical trial NCT05576350 about?

NCT05576350 is a clinical study titled "TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk". Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinki...

What is the current status of trial NCT05576350?

This trial is currently recruiting. It is a NA study. The enrollment target is 405 participants. The study started on 2024-12-09. Estimated completion is 2027-05.

What conditions does trial NCT05576350 study?

This clinical trial studies the following conditions: HIV Infections, Alcohol Use Disorder, Risk Behavior.

What interventions are being tested in trial NCT05576350?

The interventions under investigation include: Smartphone Based Alcohol Monitoring (SAM) (BEHAVIORAL), Tracking and Reducing Alcohol Consumption (TRAC) (BEHAVIORAL), TRAC-ER (BEHAVIORAL).

Who is sponsoring clinical trial NCT05576350?

This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05576350 being conducted?

This trial has 2 study locations across Connecticut, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Alcohol Use Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.